Effective for dates of service on and after April 1, 2019, and in accordance with Anthem Blue Cross and Blue Shield’s Pharmacy and Therapeutic (P&T) process, Anthem will update its commercial drug lists. Updates may include changes to drug tiers or the removal of a drug.

 

To help ensure a smooth transition and minimize member costs, providers should review these changes and consider prescribing a preferred drug to patients currently using a non-preferred drug, if appropriate. Click here to view a summary of changes.

 

Please note, this update does not apply to the Select Drug List or drugs lists utilized by the Federal Employee Program (FEP).

 



Featured In:
March 2019 Anthem Provider Newsletter - Missouri